The hepatitis C virus glycan shield and evasion of the humoral immune response
about
Activity of and effect of subcutaneous treatment with the broad-spectrum antiviral lectin griffithsin in two laboratory rodent modelsStructural basis of hepatitis C virus neutralization by broadly neutralizing antibody HCV1An alpaca nanobody inhibits hepatitis C virus entry and cell-to-cell transmissionTrimeric HIV-1-Env Structures Define Glycan Shields from Clades A, B, and GArms Race between Enveloped Viruses and the Host ERAD MachineryCell-cell contact-mediated hepatitis C virus (HCV) transfer, productive infection, and replication and their requirement for HCV receptors.Reverse epitope mapping of the E2 glycoprotein in antibody associated hepatitis C virus.Contradictory immune response in post liver transplantation hepatitis B and C.Immune control and failure in HCV infection--tipping the balance.The Humoral Immune Response to HCV: Understanding is Key to Vaccine Development.Analysis of the evolution and structure of a complex intrahost viral population in chronic hepatitis C virus mapped by ultradeep pyrosequencing.A strategy for O-glycoproteomics of enveloped viruses--the O-glycoproteome of herpes simplex virus type 1Virome Analysis of Transfusion Recipients Reveals a Novel Human Virus That Shares Genomic Features with Hepaciviruses and PegivirusesApproaching rational epitope vaccine design for hepatitis C virus with meta-server and multivalent scaffoldingLentiviral vectors displaying modified measles virus gp overcome pre-existing immunity in in vivo-like transduction of human T and B cells.Neutralizing antibodies and pathogenesis of hepatitis C virus infection.Cooperativity in virus neutralization by human monoclonal antibodies to two adjacent regions located at the amino terminus of hepatitis C virus E2 glycoproteinHepatitis C Virus Resistance to Carbohydrate-Binding AgentsImmunogenicity and functional characterization of Leishmania-derived hepatitis C virus envelope glycoprotein complex.Altered Glycosylation Patterns Increase Immunogenicity of a Subunit Hepatitis C Virus Vaccine, Inducing Neutralizing Antibodies Which Confer Protection in Mice.HVR1-mediated antibody evasion of highly infectious in vivo adapted HCV in humanised mice.Inhibition of hepatitis C virus by the cyanobacterial protein Microcystis viridis lectin: mechanistic differences between the high-mannose specific lectins MVL, CV-N, and GNA.Immunologic, metabolic and genetic factors in hepatitis C virus infection.Hepatitis C virus evasion mechanisms from neutralizing antibodiesIncorporation of hepatitis C virus E1 and E2 glycoproteins: the keystones on a peculiar virion.Progress in the development of vaccines for hepatitis C virus infection.Role of Conserved E2 Residue W420 in Receptor Binding and Hepatitis C Virus Infection.A Diverse Panel of Hepatitis C Virus Glycoproteins for Use in Vaccine Research Reveals Extremes of Monoclonal Antibody Neutralization Resistance.N-Glycosylation of Cholera Toxin B Subunit: Serendipity for Novel Plant-Made Vaccines?Structure-function analysis of hepatitis C virus envelope glycoproteins E1 and E2.Genome-wide analysis for identification of adaptive diversification between hepatitis C virus subtypes 1a and 1b.Innate and Adaptive Immune Responses in Chronic HCV Infection.Development and characterization of a human monoclonal antibody targeting the N-terminal region of hepatitis C virus envelope glycoprotein E1.Animal Cell Expression Systems.Lectin microarray and mass spectrometric analysis of hepatitis C proteins reveals N-linked glycosylation.Glycan Shielding and Modulation of Hepatitis C Virus Neutralizing Antibodies.The Janus Face of Follicular T Helper Cells in Chronic Viral Infections.Removal of the N-Glycosylation Sequon at Position N116 Located in p27 of the Respiratory Syncytial Virus Fusion Protein Elicits Enhanced Antibody Responses after DNA Immunization
P2860
Q24610025-CF03974A-0F16-4358-A2BA-0FC56C197274Q27679280-E2D30680-0BE9-4FED-BD29-45544B4880BAQ27684354-B6D1CC2C-EC82-4AE0-8650-454A7C42CA3FQ27704710-D4BFA8F0-CA76-4030-A0C6-59157CF31BA9Q28078319-5A1DB01B-226F-4720-A760-685CFD911B2DQ30541731-F3ECE815-6576-47D5-8B62-1F3ADD9C4B58Q33739145-7741FB02-F98D-434C-BE1B-D61E15B00829Q34152074-A1414163-9475-4612-9236-A3B6E6DCD87AQ34178628-4A76A28D-AE41-41E5-B19A-FC9D40F74329Q34481429-B8FD772C-F512-4892-9011-80FCD2E4536BQ34594027-E7A7EC90-91E8-4265-AC49-8E28B7CE4804Q35242303-CB90AEF3-605F-416E-A796-DD774795C32CQ35784419-8C821EA0-93E6-4054-B246-8C3D147E84E3Q35942829-F54D2BC7-FB28-427D-ACB0-BCC68F5D0616Q36220659-E2386DD8-1433-4262-A138-216DAF66E870Q36395837-73537A13-698D-4C9B-9505-5BE1FC517830Q36506935-0A0036FB-D5E1-416A-8B4C-09777B97A61CQ36576382-BC30A385-663A-4FEC-B4CE-A018041BFA43Q37144953-B3C81005-D358-49C1-9EE1-1D24F61F0EA2Q37415463-386C4408-5357-4327-BDB0-856D7EE17F57Q37471718-DBBB528F-3DF2-4C49-B41E-4EC865E37850Q37533386-085256FF-8870-4395-8A59-CC0C651A7052Q37682496-562E4631-26B9-4156-AA5D-68D9F93293B8Q37967737-B96648A8-2C0A-4CFD-9EC9-1832E8AA76BFQ38195180-9132C797-C264-4690-98C0-4741E29B4B98Q38635596-E4ABDD6D-912C-4D9A-8925-3943EF414A7EQ38765582-7A0C3B98-7816-4B8B-B95D-E65FA0D096E3Q38809451-95AE5215-9B42-4541-874F-4E8D0D947155Q40143890-C498E930-8FFD-48E5-BCFC-4D2EE3E4D78DQ40189989-CCABABE1-B0A8-4982-8F10-C36B2433D7FAQ40711741-4A12398D-3A74-4806-85E2-BD7BE85FE1A8Q41035955-F0B62134-1BB0-4036-9BE3-661372B4DF6EQ45324948-12FDF566-2A66-4714-98C1-6F7FFA9E3FD3Q47406183-798493B8-4117-4E96-984F-73B8AA7F62C7Q52593865-EE5E3FFC-975F-41C3-AA14-CC55507572D0Q53683152-27EF3EBE-578D-461E-ABBA-1BA6D41D8404Q54987756-199771AD-E532-484D-AAC7-2C221D7CB2ADQ58780345-1E566144-F6FB-49BF-9032-0EC95BD17FC5
P2860
The hepatitis C virus glycan shield and evasion of the humoral immune response
description
2011 nî lūn-bûn
@nan
2011 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
The hepatitis C virus glycan shield and evasion of the humoral immune response
@ast
The hepatitis C virus glycan shield and evasion of the humoral immune response
@en
The hepatitis C virus glycan shield and evasion of the humoral immune response
@nl
type
label
The hepatitis C virus glycan shield and evasion of the humoral immune response
@ast
The hepatitis C virus glycan shield and evasion of the humoral immune response
@en
The hepatitis C virus glycan shield and evasion of the humoral immune response
@nl
prefLabel
The hepatitis C virus glycan shield and evasion of the humoral immune response
@ast
The hepatitis C virus glycan shield and evasion of the humoral immune response
@en
The hepatitis C virus glycan shield and evasion of the humoral immune response
@nl
P2860
P921
P3181
P356
P1433
P1476
The hepatitis C virus glycan shield and evasion of the humoral immune response
@en
P2093
Gilles Duverlie
P2860
P304
P3181
P356
10.3390/V3101909
P407
P5008
P577
2011-10-01T00:00:00Z